Article ID: CBB001221532

Naming the Problem That Has No Name: Creating Targets for Standardized Drugs (2011)

unapi

Horwitz, Allan V. (Author)


Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences
Volume: 42
Pages: 427--433


Publication Date: 2011
Edition Details: Part of a special section, “Standardizing Psychotropic Drugs and Drug Practices in the Twentieth Century”
Language: English

Many of the most common types of mental health problems that are found in outpatient psychiatric and general medical practices are diffuse, undifferentiated, and amorphous. Before the 1970s this lack of specificity did not conflict with the dominant theories and treatments of the American psychiatric profession or the demands of third party insurers and regulators. However, since that time the legitimacy and solvency of the psychiatric profession has come to depend on the perception that it treats specific disease entities. The establishment of the DSM-III in 1980 provided American psychiatry with many standardized disease entities that could be precisely measured, quantified, and abstracted from their particular contexts. In the late 1980s, these entities became the targets of the new class of psychoactive drugs, the Selective Serotonin Reuptake Inhibitors. Professional, political, economic, and cultural forces that arose in a particular historical era account for the standardization of mental illnesses.

...More

Description On psychiatric drugs.


Included in

Article Pieters, Toine; Snelders, Stephen (2011) Standardizing Psychotropic Drugs and Drug Practices in the Twentieth Century: Paradox of Order and Disorder. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences (p. 412). unapi

Citation URI
https://data.isiscb.org/isis/citation/CBB001221532/

Similar Citations

Article Balz, Viola; Hoheisel, Matthias; (2011)
East-Side Story: The Standardisation of Psychotropic Drugs at the Charité Psychiatric Clinic, 1955--1970 (/isis/citation/CBB001221535/)

Article Pieters, Toine; Snelders, Stephen; (2011)
Standardizing Psychotropic Drugs and Drug Practices in the Twentieth Century: Paradox of Order and Disorder (/isis/citation/CBB001221530/)

Book Ghaemi, S. Nassir; (2013)
On Depression: Drugs, Diagnosis, and Despair in the Modern World (/isis/citation/CBB001553380/)

Book Lane, Christopher; (2007)
Shyness: How Normal Behavior Became a Sickness (/isis/citation/CBB001210279/)

Book Gaudillière, Jean-Paul; Hess, Volker; (2008)
Ways of Regulating: Therapeutic Agents between Plants, Shops and Consulting Rooms (/isis/citation/CBB001221032/)

Book Shorter, Edward; (2009)
Before Prozac: The Troubled History of Mood Disorders in Psychiatry (/isis/citation/CBB000952059/)

Chapter Hess, Volker; (2008)
Secrets, Bureaucracy and the Public Drug Regulation in Prussia of the Early 19th Century (/isis/citation/CBB001221034/)

Article Daemmrich, Arthur; Bowden, Mary Ellen; (2005)
A Rising Drug Industry: Pharmaceuticals since 1870 (/isis/citation/CBB001221029/)

Article McGoey, Linsey; (2010)
Profitable Failure: Antidepressant Drugs and the Triumph of Flawed Experiments (/isis/citation/CBB000953791/)

Chapter Simon, Jonathan; (2008)
French Serum Regulation in 1895: The Necessary Minimum or the Maximum Possible? (/isis/citation/CBB001221038/)

Book Jonathan Sadowsky; (2020)
The Empire of Depression: A New History (/isis/citation/CBB846402776/)

Article Godderis, Rebecca; (2013)
A Tricky Object to Classify: Evidence, Postpartum Depression and the DSM-IV (/isis/citation/CBB001320226/)

Article Jean-Paul Gaudillière; Lucie Gerber; (2016)
Marketing Masked Depression: Physicians, Pharmaceutical Firms, and the Redefinition of Mood Disorders in the 1960s and 1970s (/isis/citation/CBB665653849/)

Article Hirshbein, Laura D.; (2006)
Science, Gender, and the Emergence of Depression in American Psychiatry, 1952--1980 (/isis/citation/CBB000671051/)

Chapter Daemmrich, A.; Greene, J.; (2010)
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance (/isis/citation/CBB001221031/)

Authors & Contributors
Pieters, Toine
Hess, Volker
Gaudillière, Jean-Paul
Gerber, Lucie
Snelders, Stephen
Simon, Jonathan
Concepts
Pharmaceutical industry
Pharmacy
Depression
Psychiatry
Pharmacology
Psychotropic drugs
Time Periods
20th century, late
20th century
21st century
19th century
Places
United States
Great Britain
Prussia (Germany)
Switzerland
Germany
France
Institutions
Diagnostic and Statistical Manual of Mental Disorders (DSM)
United States. Food and Drug Administration
United States. Food and Drug Administration (USFDA)
Comments

Be the first to comment!

{{ comment.created_by.username }} on {{ comment.created_on | date:'medium' }}

Log in or register to comment